肿瘤坏死因子(TNF)在脓毒症中的分歧效应:实验研究的Meta分析
该Meta分析遵循PRISMA声明、方案在PROSPERO注册(CRD42020167384),检索PubMed和Embase,用SYRCLE偏倚风险工具评估,纳入175项动物研究、760个实验、19,899只动物,主要物种为小鼠(77%)和大鼠(21%)。最常见调控方式为TNF通路失活(主要与TNF不适当分泌相关),而注射TNF与TNF的适应性作用相关。LPS注射是最常用的感染模型刺激(42%)且与TNF的不适当作用强相关;活菌模型(尤其是CLP、肺炎、脑膜炎、胃肠道感染)与适应性作用相关,在单核细胞增生李斯特菌、肺炎链球菌中尤为明显。结论认为TNF在感染中的作用随实验模型而变,模拟临床条件(强毒力细菌、低接种量即高死亡率)的模型显示TNF具适应性作用,而基于LPS或低致病性活菌、剂量远高于生理阈值并联合早期抗生素治疗的模型则与不适当作用相关。
要点
- 纳入175项动物研究、760个实验、19,899只动物,小鼠占77%、大鼠占21%,用SYRCLE工具评估偏倚风险。
- TNF通路失活(主要与TNF不适当分泌相关)是最常见的调控方式;注射TNF则与TNF的适应性作用相关。
- LPS注射是最常用感染模型刺激(42%),且与TNF的不适当作用强相关。
- 活菌模型(尤其是CLP、肺炎、脑膜炎、胃肠道感染)与TNF的适应性作用相关,在单核细胞增生李斯特菌、肺炎链球菌中尤为明显。
- 模拟临床条件(强毒力细菌、低接种量即高死亡率)的模型显示TNF具适应性作用;基于LPS或低致病性活菌、剂量远高于生理阈值并联合早期抗生素治疗的模型则与不适当作用相关。
适用人群与场景
- 所有研究脓毒症相关死亡率和TNF信号调控的动物研究均符合纳入标准。
- 排除标准:缺乏死亡率数据、野生型和TNF通路改变动物7天死亡率均低于10%、无英文摘要。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,遵循PRISMA声明,方案在PROSPERO注册(CRD42020167384),检索PubMed和Embase,用SYRCLE偏倚风险工具评估。
- 共纳入175项研究、760个实验、19,899只动物;主要物种为小鼠(77%)和大鼠(21%)。
- 最常见的TNF通路调控方式为TNF通路失活,主要与TNF的不适当分泌相关;注射TNF与TNF的适应性作用相关。
- LPS注射是最常用的感染模型刺激(42%),且与TNF的不适当作用强相关;活菌模型(尤其是CLP、肺炎、脑膜炎、胃肠道感染)与适应性作用相关,在单核细胞增生李斯特菌、肺炎链球菌中尤为明显。
- 采用三种方法判定TNF作用:基于每个实验的统计学显著性、计算合并死亡率、评估死亡率的加权风险比。
证据类型、等级与局限
- 证据类型:动物实验的系统评价与Meta分析。
- 偏倚风险评估使用SYRCLE偏倚风险工具。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,TNF在感染中的作用随实验模型而变;模拟临床条件(强毒力细菌、低接种量即高死亡率)的模型显示TNF具适应性作用,而基于LPS或低致病性活菌、剂量远高于生理阈值并联合早期抗生素治疗的模型则与不适当作用相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Experimental studies in animals have yielded conflicting results on the role of Tumor Necrosis Factor (TNF) in sepsis and endotoxemia, with some reporting adaptive and others inappropriate effects. A meta-analysis of the available literature was performed to determine the factors explaining this discrepancy.
METHODS: The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The protocol was registered with PROSPERO (CRD42020167384) prior to data collection. PubMed and Embase were the databases queried. Risk of bias was evaluated using the SYRCLE Risk of Bias Tool. All animal studies investigating sepsis-related mortality and modified TNF signaling were considered eligible. The exclusion criteria were: lack of mortality data, 7-day mortality rates below 10% in both wild type and TNF-altered pathway animals, and absence of an English abstract. To determine the role of TNF according to the experimental protocol, three approaches were used: first an approach based on the statistical significance of each experiment, then the pooled mortality was calculated, and finally the weighted risk ratio for mortality was assessed.
RESULTS: A total of 175 studies were included in the analysis, comprising a total of 760 experiments and involving 19,899 animals. The main species used were mice (77%) and rats (21%). The most common method of TNF pathway modulation was TNF pathway inactivation that was primarily associated with an inappropriate secretion of TNF. At the opposite, TNF injection was associated with an adaptive role of TNF. Lipopolysaccharide (LPS) injection was the most used stimulus to establish an infectious model (42%) and was strongly associated with an inappropriate role of TNF. Conversely, live bacterial models, especially the cecal ligation and puncture (CLP) model, pneumonia, meningitis, and gastrointestinal infection, were associated with an adaptive role. This was particularly evident for Listeria monocytogenes, Streptococcus pneumoniae.
CONCLUSION: The role of TNF during infection varies depending on the experimental model used. Models that mimic clinical conditions, based on virulent bacteria that cause high mortality even at low inocula, demonstrated an adaptive role of TNF. Conversely, models based on LPS or low-pathogenic live bacteria, administered at doses well above physiological thresholds and combined with early antibiotic therapy, were associated with an inappropriate role.
参考来源
- Kassasseya C, Torsin LI, Musset C, et al. Divergent effects of tumor necrosis factor (TNF) in sepsis: a meta-analysis of experimental studies. Crit Care. 2024. PMID: 39227889. doi:10.1186/s13054-024-05057-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。